Ito, Kyoko
Yokoyama, Keitaro
Nakayama, Masaaki
Fukagawa, Masafumi
Hirakata, Hideki
Article History
Received: 28 February 2021
Accepted: 24 January 2022
First Online: 14 February 2022
Competing interests
: K.I. is an employee of Torii Pharmaceutical Co., Ltd. (TORII, Tokyo, Japan); K.Y. received consulting fees from TORII, Japan Tobacco Inc., and Kyowa Kirin Co., Ltd.; M.N. received consulting fees from TORII; M.F. received consulting fees from TORII, Japan Tobacco Inc., and Bayer Yakuhin, Ltd., and a research grant and consulting fees from Kyowa Kirin Co., Ltd. and Chugai Pharmaceutical Co., Ltd.; and H.H. received consulting fees from TORII and Japan Tobacco Inc. The ASTRIO study was conducted with funding from TORII and Japan Tobacco Inc. (Tokyo, Japan).